
Sign up to save your podcasts
Or


Joining me today is Alan Doherty, Clinical Director at the Birmingham Prostate Clinic, and recently voted one of the UK’s top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail.
Alan has been an innovator, advocate and dedicated practitioner of precision treatments for prostate cancer, and joined the Focal Therapy Clinic last year to develop his expertise in delivering focal therapy. He’s here today to talk with me about what he’s learned in the last year and how he sees the fire of focal therapy from both a provider and patient point of view.
Joining this episode of OnFocus is patient advocate & educator Andrew Gabriel, who through his own experience with prostate cancer and his advocacy work has become a well-known leader of patient support groups and a recognised source of knowledge on hormone therapy. His hugely popular talk Surviving Hormone Therapy has been attended by hundreds of patients and clinicians who value its honesty and candour. Andrew is part of Prostate Cancer UK’s Patients as Educators Programme, which support clinicians in their patient engagement.
Links to Andrew’s videos:
https://www.youtube.com/watch?v=soAzPAmhG50
https://www.youtube.com/watch?v=zAtYQZ_lT3s
TFTC Urological Consultant Tim Dudderidge, based at University Hospital Southampton, joins On Focus to discuss some of the new technologies that are coming through that we can expect to see impacting the experience and outcomes for men with prostate cancer. Tim is an innovator in focal therapy and has coinvestigated most of the clinical trials and studies that have built the evidence base for focal therapy and advanced its adoption and practice. He has recently been appointed as Clinical Champion for Prostate Cancer UK, which will give him even more impact on innovative clinical practice across the NHS.
Kirsty Rowlinson-Groves, an exercise specialist who supports men with prostate cancer in preparing for and recovering from treatment, joins On Focus to how men can benefit from programmes like the one she runs in Manchester called Prehab4Cancer This is an exercise, nutrition and wellbeing scheme run through the NHS in Greater Manchester, and has won numerous awards for its dedication, commitment and innovative approach to cancer patients across the region.
Marcus McKenzie, a teacher from South London who recently underwent prostate surgery after two years spent on Active Surveillance, joins OnFocus to discuss the heightened risk of prostate cancer that black and mixed race men face, how this impacted his experience and what all black and mixed race need to know about managing their prostate health.
TFTC patient Ian Paul joins On Focus to discuss how even the best care can go wrong and what he’s learned from his experience seeking a second opinion,
Michael Clay came to the Focal Therapy Clinic after having been placed on Active Surveillance at Torbay Hospital in South Devon. Michael’s a 76-year-old retired banker who leads a very active life with his wife and family which, despite his early-stage cancer diagnosis, was being severely compromised by his treatment. He encountered several issues which he feels are very important for all men to hear and understand before they make decisions about treatment for prostate cancer, and he’s joined On Focus to discuss these.
Professor Gordon Wishart joins On Focus to discuss the backlog of cancer referrals, diagnoses and treatments in the NHS and offer some suggestions on ways forward. Professor Wishart is
founder, Chief Medical Officer and CEO of Check4Cancer, a leading early cancer detection and cancer prevention organisation. As the former Director of the Cambridge Breast Unit from 2005-2010, and current Professor of Cancer Surgery at Anglia Ruskin School of Medicine since 2008, Professor Wishart has a strong track record in clinical research and modernisation of cancer diagnosis and treatment, with more than 100 peer-reviewed papers in scientific journals. In 2010 he led a team of clinicians and scientists that developed the PREDICT breast cancer treatment and survival model, now used worldwide.
https://www.check4cancer.com
Dr Michael Sagner, bestselling author of Lifestyle Medicine and a pioneer in preventative healthcare, joins OnFocus to discuss the changing narrative around ageing and outlines that by focusing on prevention, personalisation, prediction and participation men can impact their experiences with prostate cancer
https://www.amazon.co.uk/Lifestyle-Medicine-Environment-Preventive-Disease-ebook/dp/B06XSJ4ST9
From the publisher's feed